IP Library Assignment 033352/0916
Patent Assignment
Reel/Frame 033352/0916

Assignment of Assignor's Interest

Recorded: 2014-07-21 Pages: 6
Assignors
AUF DER MAUR, ADRIAN
Executed: 2007-08-26
BARBERIS, ALCIDE
Executed: 2007-08-20
LICHTLEN, PETER
Executed: 2007-08-20
Assignee
ESBATECH AG
WAGISTR. 21, ZURICH-SCHLIEREN, SWITZERLAND
Covered Property (1)
Method for Treating Glioblastoma Using Antibodies Binding to the Extracellular Domain of the Receptor Tyrosine Kinase Alk
Patent: 8,945,563 →
Application: 13/017,925 →
Publication: US 2011/0159008
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Jul 21, 2014
From: ESBATECH AG
To: DELENEX THERAPEUTICS AG
Reel/Frame 033353/0054 →
Change of Name Aug 8, 2016
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 039629/0573 →